Basel, Switzerland

Hans Kuhnis

This inventor holds 10 USPTO granted patents. Top assignee: Ciba-Geigy Corporation. Active years: 1976-1989.


% Patents Active = 100.0

Average Co-Inventor Count = 3.2

ph-index = 5

Forward Citations = 56(Granted Patents)


Location History:

  • Basel, C (1976)
  • Basel, CH (1977 - 1989)

Company Filing History:


Years Active: 1976-1989

Loading Chart...
10 patents (USPTO):Explore Patents

Title: Innovations of Hans Kuhnis

Introduction

Hans Kuhnis is a notable inventor based in Basel, Switzerland. He has made significant contributions to the field of chemistry, particularly in the development of compounds with cardiovascular properties. With a total of 10 patents to his name, his work has had a considerable impact on medical science.

Latest Patents

Kuhnis's latest patents include innovative compounds such as 3,5-diacyl-2,6-dialkyl-4-aryl-1,4-dihydropyridines. These compounds are recognized for their use in treating cardiovascular conditions, especially for their coronary dilatory and anti-hypertensive properties. Another significant patent involves dihydro pyridine compounds that exhibit blood pressure-reducing properties, showcasing his focus on improving cardiovascular health.

Career Highlights

Throughout his career, Hans Kuhnis has been associated with Ciba-Geigy Corporation, a prominent player in the pharmaceutical industry. His work has not only advanced scientific understanding but has also contributed to the development of effective treatments for heart-related ailments.

Collaborations

Kuhnis has collaborated with esteemed colleagues such as Kurt Eichenberger and Franz Ostermayer. These partnerships have fostered a collaborative environment that has led to innovative breakthroughs in their field.

Conclusion

Hans Kuhnis's contributions to the field of chemistry and cardiovascular health are noteworthy. His patents reflect a commitment to advancing medical science and improving patient outcomes. His work continues to inspire future innovations in the industry.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…